NCT00538343View on ClinicalTrials.gov

RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases

PHASE2TerminatedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 1, 2008

Study Completion Date

January 1, 2009

Conditions
Brain Metastases
Interventions
DRUG

berubicin hydrochloride (RTA 744)

Trial Locations (7)

23606

Virginia Oncology Associates, Newport News

25184

Duke University Medical Center, Durham

27103

Forsyth Regional Cancer Center, Winston-Salem

27403

Moses Cone Regional Cancer Center, Greensboro

28204

Presbyterian Health Care, Charlotte

33401

Palm Beach Cancer Institute, West Palm Beach

75246

Texas Oncology, PA, Dallas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY